Skip to main content
. 2019 Mar 12;42(7):962–969. doi: 10.1007/s00270-019-02200-1

Table 2.

Outcomes

n (% of 33) 95% CI
Primary outcomes (after 1 month)
Major bleeding 12 (36) 22–53
All-cause mortality 16 (49) 31–66
Secondary outcomes (after 3 months)
All-cause mortality 16 (50)a 34–66
Recurrence of VTE 1 (3)a 1–16
Other outcomes
Hospital length of stay (median days (IQR)) 17 (10–30)b

CI Confidence interval, IQR interquartile range, VTE venous thrombo-embolism

an = 32; bAssessed in all patients surviving the first month of follow-up